Asia Pacific Respiratory Care Device Market

The Asia Pacific respiratory care devices market is projected to reach USD 8.76 billion by 2031 from USD 5.85 billion in 2026, at a CAGR of 8.4% during the forecast period.

The Asia Pacific respiratory care devices market has witnessed considerable growth mainly due to the increased prevalence of respiratory diseases like COPD, asthma, and sleep apnea. These diseases are commonly associated with air pollution, smoking, and the rapidly aging populations, especially in China, India, and Japan. Furthermore, the ongoing development of healthcare infrastructure and the rise in healthcare expenditures across the region are enabling the general public to have greater access to respiratory devices for diagnosis, monitoring, and therapy. Increasing understanding of the importance of early diagnosis and disease management, along with government-supported health initiatives, is helping raise adoption even further. In addition, the trend toward home health care and portable respiratory products, as well as innovations such as connected, easy-to-use systems, are driving their use outside hospitals, making the Asia Pacific a leading market for respiratory care devices.

To know about the assumptions considered for the study download the pdf brochure

Some prominent players in the market include Koninklijke Philips N.V. (Netherlands), Medtronic (Ireland), ResMed Inc. (US), Fisher & Paykel Healthcare Limited (New Zealand), and Drägerwerk AG & Co. KGaA (Germany). These companies have deeply rooted positions in the Asia Pacific respiratory care devices market due to their wide, technologically top-notch product portfolios that include ventilators, oxygen therapy systems, sleep apnea devices, and monitoring solutions. These companies have built strong reputations and trust through their long history of clinical use. They continue to earn this trust by investing heavily in research and development, which allows them to innovate and create user-friendly devices. Their extensive distribution networks, along with local manufacturing or service presence, enable quicker market penetration and better after-sales support in key Asia Pacific countries. Additionally, strategic partnerships with hospitals, governments, and healthcare providers, as well as compliance with regional regulatory standards, enhance their ability to encourage adoption of their products. Together, their global expertise and localized market strategies provide them with a sustainable competitive advantage in this rapidly growing region.

In September 2025, Massimo expanded and renewed a multi-year partnership with Koninklijke Philips N.V., further deepening their collaboration on next-generation patient monitoring technologies, which directly drives growth in the Asia Pacific respiratory care devices market. The partnership enables an accelerated rollout of advanced monitoring solutions and the development of region-specific products, directly supporting hospitals and care providers in the Asia Pacific with better respiratory monitoring, improved critical care management, and better clinical outcomes through innovative, integrated systems.

In March 2025, Fisher & Paykel Healthcare Limited launched the F&P Nova Nasal Mask in New Zealand and Australia, further solidifying its leadership in the respiratory care devices market across the Asia Pacific. This new mask enhances comfort and fit, which is expected to improve patient compliance with CPAP therapy. The release of this product aligns with the company’s commitment to innovation and its focus on expanding its portfolio of sleep apnea and home care therapy products in the rapidly growing Asia Pacific market.

Koninklijke Philips N.V. (Netherlands)

Koninklijke Philips N.V. is one of the leading health technology companies worldwide and holds a strong position in the Asia Pacific respiratory care devices market. This is mainly because of its wide range of ventilators, oxygen therapy systems, sleep apnea (CPAP/BiPAP) devices, and patient monitoring solutions. In the Asia Pacific region, Philips uses its extensive distribution and service network covering major markets: China, India, Japan, and Southeast Asia. This not only allows for broad product availability but also provides reliable after-sales support. Philips actively participates in respiratory care in both hospital settings (acute care) and at patients’ homes, aligning with regional healthcare goals of managing chronic illnesses and enabling remote monitoring. The company's emphasis on innovative, connected care platforms and patient-friendly device designs, along with partnerships with hospitals and healthcare providers, strengthens its competitive edge and supports ongoing growth in the respiratory care devices market in the Asia Pacific.

Medtronic (Ireland)

Founded in Ireland, Medtronic is a medical technology giant with a leading market position and a diversified global footprint. The company operates in over 150 countries and has a particularly strong presence in the Asia Pacific region. One of Medtronic’s strategies has been to reorganize its respiratory portfolio, such as discontinuing the unprofitable ventilator segment; however, it remains heavily involved in respiratory and patient monitoring technologies through products like its Microstream capnography systems. These systems are most commonly used in perioperative, ICU, and emergency settings, where continuous CO2 monitoring is essential, and they are often connected to multi-parameter patient monitors. In the Asia Pacific region, the company leverages its extensive distribution channels, forms strategic partnerships, and collaborates with local healthcare providers to promote the adoption of its high-tech monitoring and critical care equipment. This approach aligns with the increasing demand driven by rising surgeries, expanded critical care capacity, and improvements in healthcare infrastructure in major markets such as China, India, and Southeast Asia. Alongside addressing local clinical needs, Medtronic’s global brand, adaptable solutions, and commitment to providing excellent service support secure its position in the respiratory care sector, especially as the market continues to grow.

Market Ranking

Koninklijke Philips N.V. is widely recognized as the leading company for respiratory care devices in the Asia Pacific region. The primary reason is that it offers the broadest and most comprehensive range of ventilators, oxygen therapy, sleep apnea solutions, and monitoring systems. Additionally, Medtronic holds a strong reputation in the market. It leverages its top-tier, globally renowned hospital and critical care respiratory product lines, along with an extensive network of clinical partnerships. ResMed Inc. is mainly known for its focus on home care and sleep apnea markets, providing the latest connected devices and digital health features. Fisher & Paykel Healthcare Limited is increasingly becoming a household name by using technology to improve its non-invasive ventilation and respiratory humidification solutions. These innovations are gaining popularity in both hospital and home care settings. Lastly, Drägerwerk AG & Co. KGaA maintains its strong position through reliable ventilators and critical care respiratory systems, especially in acute care environments. These companies collectively sustain their dominance over local competitors in the Asia Pacific region through their comprehensive portfolios, technological innovations, and strong regional distribution networks.

Related Reports:

Asia Pacific Respiratory Care Device Market by Product (PAP Devices, Ventilators, Humidifiers, Oxygen Concentrators, Spirometers, Peak Flow Meter, Masks), Disease Indication (Asthma, Infectious Disease), & End User (Hospitals, ASCs) - Forecast to 2031

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
sales@marketsandmarkets.com